Back to search
FDAFDA · Food and drugs·Recall number Z-1252-2018

Revolution CMS w/ Femoral Breakaway Nozzle & Med. Press., Product Number: 0606-573-000, UDI: (01)4546540912114 for orthopedic use.

Published April 4, 2018 · Recall initiated: November 9, 2017

Summary

FDA records medical device Class II recall Z-1252-2018, published April 4, 2018 and initiated November 9, 2017. Recalling firm: Stryker Instruments Div. of Stryker Corporation; Status: Terminated; Reported quantity: 732; Lot: Lot Number: 17290012 UDI: (01)4546540912114. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of sterility assurance as bioburden levels were found to be higher than internal acceptable rates.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Stryker Instruments Div. of Stryker Corporation
Distributor
Distributed in all 50 U.S. States and the District of Columbia. Distributed in Australia, Argentina, Japan, Canada, Chile, Korea, Spain, France, Italy, Netherlands, and United Kingdom.
Lot
Lot Number: 17290012 UDI: (01)4546540912114
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Revolution CMS w/ Femoral Breakaway Nozzle & Med. Press., Product Number: 0606-573-000, UDI: (01)4546540912114 for orthopedic use. recalled?

Yes. FDA published recall Z-1252-2018 on April 4, 2018. Reported hazard: Lack of sterility assurance as bioburden levels were found to be higher than internal acceptable rates.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail